A First-Time-in-Human Randomised, Single Blind Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics, of Single Escalating Doses of GSK1482160, in Male and Female Healthy Subjects, and to Make a Preliminary Assessment of the Effect of Food.
Phase of Trial: Phase I
Latest Information Update: 11 Jul 2017
At a glance
- Drugs GSK 1482160 (Primary)
- Indications Inflammatory pain
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- Sponsors GlaxoSmithKline
- 13 Aug 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 13 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2009 New trial record